Business · 06/10/2026
FDA Clears Pralidoxime Chloride Autoinjector for Sale
The US Food and Drug Administration has ruled that the Pralidoxime Chloride Autoinjector, a 600mg/2mL solution, was not withdrawn from the market due to safety or effectiveness concerns.